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 Abstract:  
Gene-Environment interactions approach could explain some epidemiological and clinical 
factors associated to addictive behaviors. Twin studies first help to disentangle the respective 
role of environment and genetic effects, finding convincing evidence for common genetic 
vulnerability in several addictive behaviors, and helping to delimit what syndrome could 
belong to the addictive disorder spectrum. Assessing gene x environment interaction (GxE), 
need specifically designed studies, using multiplicative or additive approaches. Focusing on 
this GxE interaction already showed its relevancy in many recent studies, using both 
epidemiological and molecular approaches. For example, in a non-human primate model of 
alcohol dependence assessing the respective role of genetic vulnerability (having the short 
allele located in the promoter region of the gene coding for the serotonin transporter) and 
severe fostering conditions (as locked up in a cage with other inmates for the first 6 months of 
life), the only group that has a significant risk of using spontaneously alcohol is the group of 
monkeys that have both risk factors, i.e. being peer-raised and having the short allele. 
Such approach could help to more accurately select specific candidate genes, to identify more 
homogenous subgroups of patients (as sharing the same genetic vulnerability), to understand 
how genetic factors mediate the risk for associated psychiatric disorders, and ultimately, may 
lead to more focused, i.e. more efficient, prevention strategies. 
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Résumé  
Les études épidémiologiques sont informatives et concordantes quant aux facteurs faisant 
varier en fréquence les conduites addictives (sexe, âge, statut marital, trouble psychiatrique et 
surtout dépendance à une autre substance). Or, le rôle de ces facteurs dont certains relèvent de 
l’environnement est à confronter à l’importance d’une vulnérabilité génétique aux addictions.  
Les études de jumeaux aident à quantifier le poids respectif de l’environnement et de 
l’hérédité. Elles retrouvent de manière homogène un poids significatif des gènes dans la 
vulnérabilité aux dépendances quelque soit la substance voir l’objet de cette dépendance 
(substances ou comportement). Plus encore, ces études montrent qu’au sein de l’hérédité des 
addictions, une vulnérabilité génétique commune compte plus que la part spécifique de gène à 
chaque dépendance.  Elles aident ainsi à préciser le phénotype héritable comme relevant de 
conduites addictives associées entre elles et à d’autres troubles comportementaux comme les 
conduites agressives précoces et l’hyperactivité. 
Pour autant, malgré les arguments en faveur de l’intervention de gènes majeurs dans cette 
vulnérabilité, aucun allèle n’a pu être clairement impliqué. L’hétérogénéité du phénotype, les 
phénomènes de phénocopies et de pénétrance incomplète, comme les interactions épistatiques 
pourraient expliquer ces difficultés. La prise en compte conjuguée des facteurs génétiques et 
environnementaux doit permettre de mieux déterminer les facteurs de vulnérabilité impliqués 
ainsi que la manière dont ils s’associent.  
L’étude de l’interaction gène-environnement (GxE) apporte certains éléments de réponse. 
Plusieurs méthodes permettent d’estimer cette interaction. La première dite « multiplicative » 
mesure si l’exposition aux deux facteurs (RR(GxE)) présente un risque relatif au dessus ou en 
dessous de celui attendu en multipliant le risque relatif du facteur environnemental ou 
génétique isolément. La deuxième méthode est dite « additive ». Elle compare simplement la 
différence entre le risque lié à la présence des deux facteurs à l’addition des risques de chacun 
 3
H
AL author m
anuscript    inserm
-00150412, version 1
d’entre eux. Ces différentes méthodes permettent de différencier la corrélation gène-
environnement (rGE) de l’interaction GxE  proprement dite. Cette approche peut ainsi 
permettre d’identifier les groupes les plus génétiquement vulnérables à l’environnement. Elle 
a ainsi son importance dans les stratégies de prévention.  
Certaines études récentes ont prouvés ce type d’interaction. Par exemple, une étude 
d’adoption montre que les conduites agressives de l’enfant adopté étaient associées en 
fréquence à une alcoolo-dépendance chez les parents biologiques uniquement en cas 
d’environnement familial perturbé dans la famille adoptive. Ce type d’interaction est 
également montré au niveau moléculaire. Dans une étude portant sur les singes rhésus, la 
séparation précoce du nouveau né entraîne un risque de consommation d’alcool uniquement 
en présence de l’allèle court d’un polymorphisme du promoteur de la sérotonine. Chez 
l’homme, ce type d’interaction est montré par des protocoles de pharmacogénétique (variation 
de l’efficacité de la Naltrexone dans la dépendance à l’alcool en fonction d’un polymorphisme 
d’un récepteur opioïde); ou dans la sévérité des symptômes de sevrage à l’alcool, voire des 
complications de sevrage en fonction du génotype du transporteur de la dopamine. Ces 
résultats chez l’homme sont d’autant plus pertinents qu’ils concernent tous deux des 
molécules centrales du système de récompense, voie biologique candidate principale dans la 
vulnérabilité aux dépendances en général. 
La mesure précise de ce type d’interaction GxE s’est donc déjà montrée pertinente. Elle 
devrait se poursuivre sur des échantillons conséquents, permettant de définir d’une part les 
environnements précisément « à risque », d’autre part, les gènes de vulnérabilité, et enfin, la 
manière dont ils s’associent dans les troubles psychiatriques, pathologies éminemment 
multifactorielles. 
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1. Epidemiology of addictive disorders 
 
Alcohol and illicit drug abuse are among the top 10 major risk factors in global burden of 
mortality and morbidity according to the assessments based on the DALY (Disability adjusted 
life years) [1]. Epidemiology of addictive disorders need to analyse both clinical and general 
population samples to understand the complex relationships between drinking/ drug use, 
drinking problems/drug related problems, alcohol/drug abuse or dependence and to measure 
consequences (mortality, somatic and psychiatric co-morbidity, social difficulties, antisocial 
and criminal behaviours,…) of these addictions. 
The estimations of abuse and dependence prevalences for any type of addictive substance are 
based on a limited number of studies. Five large epidemiologic researches based on the 
general population have examined the co-morbidity of alcohol and drug use disorders 
worldwide. The Epidemiologic Catchment Area (ECA) in the 1980s [2], the National 
Comorbidity Survey (NCS) [3], the National Longitudinal Alcohol Epidemiologic Survey 
(NLAES) [4] were all made in the United States of America. The 1990 Mental Health 
Supplement of the Ontario Canada Health Survey (MHS-OHS: [5]) and the 1997 Australian 
National Survey of Mental Health and Well Being (NSMHWB: [6]) were also derived from a 
large sample of the general population. Unfortunately, such a study was not performed in 
France, although the latter has one of the most important consumption of alcohol in the world. 
Indeed, according to one study focusing on consumption, the French general population 
(between 18 and 75 years old) had a high prevalence rates of alcohol regular use (31%), 
tobacco (29%), cannabis (1,4%) and cocaine or heroin (0.4%) in 2002 [7]. The only 
information we have is derived from the ESCAPAD study, a one month prevalence of drug 
use among young people, between 17 and 18 years old. The estimated prevalence was 1% for 
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poppers, 0.7 % for solvents, 0. 9% for cocaine, 0.9% for amphetamines, 0.5% for LSD, 1.6% 
for Ectasy , 0.4% for Heroin and 0.3% for crack [8]. 
The most interesting study on this topic is the NESARC [9], which recently analysed a large 
(more than 43,000 subjects) representative sample of the U.S. population, examining current 
prevalences and associations between alcohol and specific drug use disorders. 
The one-year prevalence rates of abuse or dependence are ranging from 0.02% (cocaine 
dependence) to 1.13% for cannabis abuse (Table I). These frequencies are limited to 
syndromic addictions that were observed during the current year.  
More interestingly, a large number of parameters were analysed in the groups of patients with, 
or without, any addictive disorder (Table II). It can be observed that not only males are more 
exposed to any addictive disorders, but they are also more exposed to co-morbid addictive 
disorders (alcohol and drug abuse or dependence). One of the interesting ideas of the 
NESARC study was to enrich subgroup of subjects from ethnic minorities. With this 
approach, they showed that African persons are more exposed to any drug abuse or 
dependence, Asians are less exposed to alcohol abuse or dependence, and subjects with 
Hispanic origins are more frequently observed in the group of co-morbid addictive disorders. 
The NESARC study also confirmed that young subjects (18-29) are more at risk, as subjects 
who were never married. Personality disorder and past year anxiety or mood disorders were 
associated with a dramatically increase of any abuse or dependence diagnosis, an important 
result regarding the effort which were made in the NESARC study to correctly assess such co-
morbidity, usually very difficult to disentangle. Another major replication of the NESARC 
investigation is the very high co-morbidity of addictive dependencies, presence of one 
dependence dramatically increasing the risk of dependence for another substance (table III), 
up to 43 times increased risk (OR=43) of alcohol dependence in patients with cocaine 
dependence.  
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The role of environmental risk factors is not in contradiction with a genetic approach of 
addictive disorders, as vulnerability genes might lead to the disorder through these factors. 
For example if genes coding for male hormones are involved in opiate dependence, gender is 
a risk factor through genetics. An alternative explanation is that environmental factors might 
decrease the threshold, allowing the genetic vulnerability to be expressed. For example, if 
stressful life events are associated with an increased risk of relapse in alcohol dependence, the 
role of the gene coding for the serotonin transporter (the target of antidepressive drug) might 
be involved, and only observable in patients exposed to such revealing conditions. 
 
2. Genetics of addictive disorders 
 
The heritability concept relates to the percentage of the total variance of a disorder that is 
explained by genes. It is usually computed on the basis of twin studies that help to disentangle 
the respective role of the specific environment (the part of the environment that is not shared 
by the two twins in the same family, whether they are monozygotic or dizygotic), the shared 
or family environment (by definition comparable between two twins raised in the same 
families, at the same period of time… roughly comparable for monozygotic and dizygotic 
twins) and addictive genetic effects (i.e., heritability, which is nearly the only source of 
difference between the two types of twins). Indeed, monozygotic twins share 100% of their 
genes (as it is the same oocyte, fertilized by the same spermatoid, that led to only one embryo 
which is accidentally divided in two after fertilization) and dizigotic twins share only 50% of 
their genes (as they come from two different oocytes, fertilized by two different spermatoids, 
as all sibs). 
Many twin studies were performed on addictive disorders. In alcohol consumption, the 
heritability is relatively high (h²=43%) [10], as it is for tobacco use, especially for those that 
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consume a large amount of cigarettes per day (h² up to 70%) [11]. Usage of hallucinogens, 
opiates and sedatives are also associated with a relatively high heritability [12].  
Interestingly, the role of shared (familial) environment is usually not significantly different 
from 0, at least for hallucinogens, opiates and sedative [12], the involved risk factors could 
therefore mainly concern genes and specific environment. The heritability of addictive 
disorders is largely variable from one study to another, which is not surprising as patients are 
collected in very different ways, using different instruments and collected from different 
settings. The Virginie cohort from Kendler and some of the Australian studies relate to the 
general population, and a large part of other studies are based on treated population. Roughly, 
the heritability of addictive disorders is higher for abuse than for usage, and for dependence 
than for abuse, ranging between 21% and 72%. The heritability scores of substance abuse or 
dependence have surprisingly a low level of covariance with the heritability score observed in 
substance consumption., i.e., the genes involved in consumption are not systematically 
involved in abuse or dependence, and vice-versa. 
Some twin studies focused on this problem, assessing the cross-twin cross-trait heritability to 
pinpoint the shared heritability between two different addictive disorders. Tsuang et al. [13], 
for example, showed that a large majority of the genes involved are common to the different 
disorders, with the role of genes for one specific disorder being 0% for LSD, 15% for 
sedatives, 25% for stimulants and 33% for cannabis [13]. In another study, the co-morbidity 
between pathological gambling and alcohol dependence is mainly depending on the same 
genes, the heritability ranging between 12% and 75% [14-15]. All studies are not that clear for 
the existence of a common genetic basis in the different addictive disorders [16]. 
Nevertheless, when researches are focusing not only to initiation, maintenance or level of 
consumption, but rather on dependence symptoms, then the involved genes might be much 
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more frequently common than different, explaining in part, for example, the high co-
morbidity between cigarette and alcohol dependence [17]. 
Few studies have been performed on behavioural addictive disorders, such as 
pathological gambling. In the same line with what is observed for chemical addictions, the 
more frequent an addictive behaviour is performed with deleterious consequences, the higher 
is the heritability (h²=35% when the gambling was made at least 25 times a year, and 54% 
when two symptoms of pathological gambling are detected). 
It is not easy to delimit what syndrome belongs to the addictive disorder spectrum. 
Indeed, Cloninger [18] showed that alcohol dependence is not really inherited, but rather that 
a subgroup of patients is especially concerned by genetic vulnerability, with young age at 
onset, severe dependence, male gender, and antisocial behaviour, this group of patients 
explaining a large proportion of the alcohol dependence heritability. Such type II male limited 
alcoholism has in fact a 88% heritability, while type I alcoholism only has a heritability of 
21%. 
 
3. The definition of GxE interaction 
 
The fact that so important evidence favours the hypothesis of a major role of genes in the 
development of any abuse or dependence is counterbalanced by the absence of vulnerability 
genes that has yet been definitely involved. Indeed, the only genes that have a clear-cut role in 
alcohol or tobacco dependence are more devoted to protection than to vulnerability [19], and 
are related to the metabolism of the drug rather than to temperament, psychiatric vulnerability, 
or social behaviour. Many reasons could be raised to explain such discrepancy. 
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- The absence of valid criteria for the concepts of abuse or dependence is an important 
limitation, as the criteria used for the diagnosis are chosen for their clinical relevance, not 
according to genetic studies. 
- Presence of phenotypical heterogeneity is also a source of problem, as not all cases 
of addictive disorder for different types of drug or behavior share the same mechanisms. 
Accordingly, analysing samples of patients with different type of dependence, based on 
different risk factors (see table II) may add confusion rather than increase the power of the 
statistical analyses. 
- The “phenocopy” and “incomplete penetrance” phenomenon could act as a break 
upon the discovery of vulnerability genes too. Some patients may indeed have a dependence 
for reasons that are independent of genetic vulnerability, (i.e., phenocopy) and not all cases of 
genetically vulnerable patients will have the disorder at least once in their life (i.e., incomplete 
penetrance) 
- Epistatic interaction (i.e., different combination of genes might explain the disorder 
rather than isolated gene) is also rarely taken into account in genetic analyses of addictive 
disorders.  
 
A highlighting way of facing these problems is mixing the approaches devoted to 
environmental factors with those devoted to genetic analyses. Such gene x environment 
interaction (usually untitled “GxE interaction”), is a domain of research that only recently led 
to specifically designed studies, and which may constitute an interesting way of dealing with 
phenotypical heterogeneity. Looking at the role of a gene in a group of patient sharing the 
same environmental risk factor does clearly reduce the heterogeneity of the phenotype. The 
limitations of phenocopy and incomplete penetrance are also largely reduced this way, for the 
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same reasons. Furthermore, the reliability of the studied concepts could be considered as 
enhanced when both environmental and genetic aspects are considered. 
For example, being male, Caucasian, between 18 and 29 years old, never married, with a low 
level of education, with a personality disorder and with lifetime mood and/or anxiety disorder 
is associated with a dramatically increased risk of any addictive disorder. Such group of 
patients has more chance to share common vulnerability genes, as they represent a more 
homogenous sample. Specific risk factors may also help to pinpoint some candidate genes. 
For example, as mood disorder is associated with an increased risk of alcohol or drug 
abuse/dependence, patients with both alcohol dependence and independent major depressive 
disorder could have more chance to have vulnerability genes involved in these two disorders, 
such as those related to serotonin receptors, transports and metabolism.  
The way to assess GxE interaction can be written in a table (table IV) or presented in a figure 
(figure 1). There are several methods to assess the statistical significance of interactions [20]. 
The first one is multiplicative, and measure if those exposed to both risk factors (RR[GxE]) 
have a relative risk which is above (supermultiplicative) or below (submultiplicative) the one 
expected by multiplying the relative risk for environmental exposure (RR[E]) or genetic 
predisposition alone (RR[G]). This leads to assess if RR[GxE] is greater than the 
multiplication of RR[G] and RR[E]. The second method is an additive approach, and focuses 
on differences between the risk observed in RR[GxE] (exposed to both risk factors) and 
RR[E] + RR[G] (adding the two individual risks).  
Other types of advantages can be raised for the GxE interaction approach. For example, the 
statistical power of the analyses might be particularly crucial in complex disorders and 
neuroscience research. If a gene has a moderate global role but a strong effect in a subsample 
(that share common vulnerability factors), limiting the analyses to this group of patients may 
help to discover genes that would never have been found in the general population. 
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Furthermore, the path between presence of vulnerability factors to the onset of an addictive 
disorder should be easier to understand, as genetic are always the first risk factors in the 
causal chain. When analysing the performance of prevention strategies, such approach could 
lead to focus on more vulnerable group(s) (i.e. those with vulnerability genes) in order to 
avoid (if possible) the environmental vulnerability factors, or alternatively to reinforce their 
coping strategies in order to reduce the deleterious effect of such environmental factor.  
 
4. Evidence for and examples of GxE interactions in addictive disorders 
 
Before the first molecular genetic analyses have been performed in different addictive 
disorders, evidence was raised in favour of a GxE interaction in the 80’s. In an adoption 
study, Cadoret et al. [21] showed, for example, that both presence of alcohol dependence in 
the educative parents and presence of alcohol dependence in biological parents (who did not 
raise their children) are risk factors for alcohol dependence in adoptive children, showing that 
genetic and familial environmental factors are both involved. Interestingly, he found that 
alcohol dependence in the biological parents increased the risk of aggressivity of the adoptive 
child, and that this aggressivity leads to antisocial disorder (OR=8.9) only when the children 
are raised in a disturbed adoptive family (OR=3.2). Antisocial personality disorder being the 
most important risk factor for any alcohol or drug abuse or dependence, a GxE interaction 
was therefore shown. 
 
One particularity of GxE analysis (genetically influenced sensitivity to the 
environment) relates to rG.E correlation (association between genetic and environmental 
risks), when the genetic factors are not associated with a more deleterious effect of an 
environmental stress, but rather increases the risk to be exposed to such negative elements. 
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Such bias may lead to erroneous conclusions as it is not a real interaction, but rather a 
correlation of these two risk factors. A heuristic example of such rG.E correlation was 
detected when assessing the heritability of cigarette smoking in different cohorts according to 
age. Kendler showed [22] that the heritability of cigarette smoking is around 60% for young 
cohorts of male and female subjects. But for female patients around 60 years old the 
heritability drop to 20%, and is not any more significantly different from 0 for even older 
cohorts (born between 1910 and 1924). Interestingly, the heritability of tobacco smoking is 
not variable in male cohorts according to age. This study shows that when access to an 
addictive substance is decreasing (for life habits, social image or other reasons), the chance to 
prove a role of genetic factors is also decreasing. Indeed, with very few tobacco dependence 
in old female cohorts (probably because in the past cigarette smoking was considered as a 
male behaviour) it was not possible to analyse any risk factor, as social gaiting was censoring 
all other factors.  
 
A more direct assessment of GxE interaction was tested in a non-human primate 
model of alcohol dependence [23]. In this protocol, young rhesus monkeys were split in two 
groups according to a genetic polymorphism of the promoter region of the serotonin 
transporter (5-HTT), those having, or not, the short variant of the 5-HTTLPR polymorphism. 
This allele was previously associated to alcohol dependence [24,25] and has the particularity 
to be perfectly common in human and non-human primates. As this gene was also associated 
with mood and anxiety disorder, the authors made the hypothesis that very stressful 
upbringing conditions would enhance their risk to maintain initially induced alcohol 
consumption (environmental effect), especially in vulnerable monkeys (genetic effect). In 
accordance with their hypothesis, the monkeys that were separated from their mothers at birth 
and locked up in a cage with other inmates (i.e. peer-raised) for the first 6 months of life had a 
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higher alcohol consumption, whereas monkeys with the short allele also had an increased 
spontaneous alcohol consumption. The striking finding is in fact that none of this two factors 
should have been considered alone, as being peer-raised is not associated with an increase of 
alcohol consumption when the rhesus monkeys do not have the short allele, and as having the 
short allele is not associated with an increased alcohol consumption in the group of monkeys 
that were raised by their mother. Indeed, the only group that has a significant risk of using 
spontaneously alcohol is the group of monkeys that have both risk factors, i.e. being peer-
raised and having the short allele. 
 
 Another aspect of GxE interaction in addictive disorders relates to 
psychopharmacogenetics. The treatment can be considered as an environmental effect on a 
subject, which might be variable according to different genetic polymorphisms. For example, 
naltrexone has shown a good efficacy in alcohol dependence [26]. The role of naltrexone is to 
reduce, after withdrawal, the risk of relapse, the intensity of alcohol craving and days in 
which alcohol is consumed. However, positive response to naltrexone is variable [27]. The 
endogenous opioid system was therefore assessed as a potential predictor of treatment 
response, as naltrexone exerts its action as a mu receptor antagonist. One such 
psychopharmacogenetic study analysed the impact of a μ-opioid receptor OPRM1 gene 
polymorphism on naltrexone efficacy in 82 alcohol-dependent patients compared to 59 
controls, namely alcohol-dependent patients who were randomized to placebo [28]. Subjects 
with one or two copies of the 118G allele have shown a significantly lower rate of relapse and 
a longer time to return to heavy drinking than patients homozygous for the 118A allele.  
 
 As the mesolimbic dopaminergic system plays a key role in reward pathway, the genes 
involved in central dopamine functions are frequently studied in alcohol dependence. The 
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gene encoding the dopamine transporter (DAT) could be a good candidate gene because this 
membrane-bound protein is essential for the homeostatic regulation of dopaminergic 
neurotransmission [29]. Given the heterogeneous results of the case-control association 
studies, particularly those on alcohol-dependent patients, it may be interesting to restrict this 
kind of study to more homogeneous subgroups of patients, taken into account the 
environmental effects. A key period to assess dependence is the withdrawal period, as acutely 
stopping alcohol consumption is an environmental factor that may highlight genetic 
vulnerability to severe dependence. A significant association between the 9-copy repeat allele 
(A9 allele) of a variable-number tandem repeat in the 3’ untranslated region of the DAT gene 
and two withdrawal complications, namely delirium tremens and alcohol withdrawal seizure 
were reported [30-31]. In addition, Schmidt et al. [32] found that withdrawal symptoms were 
more severe in alcohol-dependent patients carrying the A9 allele than among patients without 
this variant. Wernicke et al. also [33] tested two other polymorphisms in the 3’UTR of the 
DAT gene, and found a higher prevalence of A/A homozygosity in patients with a history of 
severe complications. Lastly, the only sample that analyzed female alcohol dependent patients 
showed also that the A9 allele could constitute a risk factor for severe withdrawal 
complications, in this sample, patients with the A9 allele have more hallucinations than those 
without the vulnerability allele [34]. Therefore, the role of the DAT gene is not increasing the 
risk of alcohol dependence per se, but rather, when patients are exposed to an acute 
withdrawal of their consumption, is associated with an increased risk of life-threatening 
complications, at least for five different studies. Putting to the fore this vulnerability gene in 
alcohol dependence thus required to determine (for hospitalized patients in order to get 
abstinence), control (when treating alcohol dependent outpatients, a strict medical supervision 
is required) or at least assess (as accidental withdrawal periods exist, it is important to 
measure the suddenness and length of such phases) withdrawal conditions, this specific 
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situation constituting an environmental trigger that allowed to show the role of a vulnerability 
gene.  
 
5. Conclusions 
 
Assessing the role of the environment factors that are involved in addictive disorders while 
taking into account the existence of a genetic vulnerability is logical, this being true the other 
way round. On the other hand, adding another factor, and taking into account the interaction 
between different these two factors, also have some limitations. Assessing GxE interactions is 
more difficult as requiring specially designed studies [20], as they are more informative in 
large cohort of different subgroups initially selected on the basis of presence versus absence 
of each risk factor and followed-up for long period of times. Hence, this type of protocol is 
particularly difficult to perform in such populations with large drop out rates, and such 
disorder that has so many environmental risk factors (each with a moderate to low impact) 
and with no gene already considered as obviously involved. Moreover, environmental risk 
factors are different from early embryonic development through gestation and birth and 
onward toward children and later stages of development [35]. 
Nevertheless, focusing on this GxE interaction already showed its relevancy. Facing 
the environmental factors involved to the genetic vulnerability helps to select specific 
candidate genes. Delimiting definite sets of environmental risk factors also favour the 
selection of more homogenous subgroups of patients that have higher chance to share the 
same vulnerability genes. Moreover, psycho-experimental protocols can also be proposed, as 
some of the environmental factors are controllable. Assessing the initial tolerance to the 
cognitive and motor effect of moderate amount of alcohol injection in sons of alcohol 
dependent fathers [36] was already analyzed, for example, with interesting genetic results. In 
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addition, prevention strategies would gain in efficacy when focusing on vulnerable groups (as 
having the vulnerability allele) and specific sets of environmental factors (trying to reduce its 
deleterious impact). 
The shift from purely environmental studies to genetic research in addictive disorder is 
still recent, with promising but up to now disappointing results. Such cleavage probably has 
an internal coherence (not using the same tools) but probably has to be overtaken to get closer 
to what is happening in real life, i.e. the way we cope with addictive substances is a mix up of 
many environmental effects, the genes that we are made of, and a large interaction between 
these two phenomenon.  
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Figure 1: Two types of interaction between a gene (with or without the muted allele) 
and one environmental factor (with a quantitative variable exposure to an environmental risk 
factor) in order to explain an increased global risk for a disorder. 
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Table I: One-year prevalence of DSM-IV abuse and dependence in the USA (NESARC 
study) [7]. 
 
Drug          Abuse       Dependence 
    %           (s.e.)         %           (s.e.)          
Tranquilizer 0.08 (0.02) 0.05 (0.01) 
Sedative 0.09 (0.02) 0.07 (0.01)  
Amphetamine 0.09 (0.02) 0.07 (0.02) 
Hallucinogen 0.12 (0.02) 0.02 (0.01) 
Cocaine 0.13 (0.02) 0.13 (0.02) 
Opioid 0.24 (0.04) 0.11 (0.02) 
Cannabis 1.13 (0.06) 0.32 (0.04) 
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Table II: Demographic characteristics and psychiatric morbidity of subjects with, versus 
without, DSM-IV drug and/or alcohol use disorder (NESARC study [7]). 
 
Characteristics            Use disorder        
       Alcohol   Drug (any) Alcohol and drug       None    
 
Gender Male 69.4 (1.04) 60.1 (2.97) 73.9 (2.64) 45.7 (0.32) 
 Female 30.6 (1.04) 39.9 (2.97) 26.1 (2.64) 54.3 (0.32) 
 
Ethnicity White 75.8 (1.85) 68.5 (2.90) 68.5 (3.06) 70.6 (1.61) 
 Black   8.7 (0.67) 15.8 (2.14) 11.5 (1.83) 11.2 (0.65) 
 Asian   2.3 (0.48)   3.6 (1.61)   2.6 (0.99)   4.6 (0.56) 
 Hispanic 10.8(1.59)   8.9 (1.88) 11.0 (1.82) 11.7 (1.23) 
 
Age 18-29 38.3 (1.18) 47.8 (3.30) 65.0 (3.02) 19.7 (0.37) 
 30-44 37.0 (1.09) 33.8 (3.19) 25.9 (2.63) 30.4 (0.33) 
 45-64 21.6 (0.98) 15.9 (2.31)   9.1 (1.85) 32.3 (0.32) 
 >65   3.2 (0.34)   2.6 (0.78)   0.1 (0.07) 17.6 (0.37) 
 
Marital status Married 47.7 (1.08) 45.0 (3.14) 20.2 (2.21) 63.4 (0.50) 
 Separated 16.7 (0.85) 12.8 (1.96) 16.6 (2.18) 17.6 (0.24) 
 Never married 35.6 (1.21) 42.2 (3.04) 63.2 (2.80) 19.0 (0.49) 
 
Education  <high school  12.2 (0.98) 18.3 (2.51)  18.2 (2.67) 15.9 (0.49) 
 High school 27.9 (1.09) 38.1 (3.29) 33.3 (2.77) 29.3 (0.56) 
 > high school 59.8 (1.32) 43.6 (2.93) 48.4 (3.01) 54.8 (0.63) 
 
Income (US $) 0-20.000 39.3 (1.22) 66.1 (3.31) 65.4 (2.89) 47.5 (0.59) 
 20.000-35.000 25.8 (1.06) 18.7 (2.69) 23.1 (2.45) 22.4 (0.36) 
 35.000-70.000 25.5 (1.00) 11.3 (2.13)   9.7 (1.61) 21.9 (0.40) 
 >70.000   9.4 (0.71)   4.0 (1.68)   1.8 (0.72)   8.2 (0.38) 
Urbanicity Urban 79.6 (1.83) 84.3 (2.60) 78.4 (3.09) 80.3 (1.62) 
 Rural 20.4 (1.83) 15.7 (2.60) 21.6 (3.09) 19.7 (1.62) 
 
Personality Disorder 25.3 (1.00) 44.0 (3.45) 50.8 (3.05) 13.2 (0.33) 
 No disorder 74.7 (1.00) 56.0 (3.45) 49.2 (3.05) 86.8 (0.33) 
 
Past-year independent mood disorder 
 Yes 16.4 (0.81) 27.5 (2.58) 35.3 (3.32)   8.1 (0.21) 
 No 83.6 (0.81) 72.5 (2.58) 64.7 (3.32) 91.9 (0.21) 
 
Past-year independent anxiety disorder 
 Yes 15.6 (0.86) 24.0 (2.66) 26.5 (2.82) 10.4 (0.32) 
 No 84.4 (0.86) 76.0 (2.66) 73.5 (2.82) 89.6 (0.32) 
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Table III: Risk increase (adjusted odds ratio with 95% confidence interval) for alcohol abuse 
or dependence of patients with drug abuse or dependence (controlling the role of 
sociodemographic factors, personality disorder, 12-month independent mood disorder and 
independent anxiety disorder). 
 
Drug   Abuse   Dependence 
Sedative   5.3 (2.44–11.31)    1.8 (  0.65–    4.93) 
Tranquilizer   7.1 (2.52–20.17)    4.0 (  1.30–  12.16) 
Cannabis   6.2 (4.80–  7.90)   7.3 (  3.92–  13.72) 
Any   5.7 (4.49–  7.30)   9.9 (  6.47–  15.01) 
Opioid   6.1 (3.76–  9.91) 12.9 (  6.18–  26.89) 
Amphetamine   5.2 (2.14–12.59) 20.3 (  6.18–  66.94) 
Cocaine 10.5 (4.85–22.56) 43.0 (17.83–103.49) 
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Table IV: Assessing GxE interaction on the basis of presence versus absence of each risk 
factor (genetic and environmental). 
 
Vulnerability gene (G) Environmental factor (E) 
    Absent  Present 
Absent    RR=1  RR[E] 
Present   RR[G]  RR[GxE] 
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